POU2F3 and neoplasm: Variations in study design, the organs involved, associated tumour types, detection methods for POU2F3 expression – including differences in immunohistochemical protocols, antibodies used and types of biomaterials – and criteria for defining POU2F3 positivity may have introduced bias and affected the comparability of results.